KIDNEY TRANSPLANT FAILURE AND REJECTION
Clinical trials for KIDNEY TRANSPLANT FAILURE AND REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT FAILURE AND REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT FAILURE AND REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop kidney rejection
Disease control Not yet recruitingThis early study tests a new medicine called TNX-1500 in 5 people who get a kidney transplant. The goal is to see if it is safe and can help prevent the body from rejecting the new kidney. Participants will be followed for one year to check for side effects and signs of rejection…
Matched conditions: KIDNEY TRANSPLANT FAILURE AND REJECTION
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Light therapy and donor cells aim to stop kidney rejection
Disease control Not yet recruitingThis early-stage trial tests whether giving kidney transplant recipients a special treatment made from their donor's cells, combined with a light-based therapy called photopheresis, can safely reduce the risk of organ rejection. About 24 adults receiving their first kidney transp…
Matched conditions: KIDNEY TRANSPLANT FAILURE AND REJECTION
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC